No link between lung cancer risk, reproductive history or hormone use
the ONA take:
According to results published in the Journal of Thoracic Oncology, researchers from the Women's Health Initiative Studies have found no strong associations between lung cancer risk in women and reproductive history and a weak association between lung cancer risk and hormone use.
The Women's Health Initiative Studies included a diverse cohort of 161,808 postmenopausal women aged 50-79 years at numerous centers across the United Stated.
For this particular analysis, researchers evaluated reproductive history, oral contraceptive use, and hormone replacement therapy in 160,855 women. Researchers identified 2,467 women who developed lung cancer during the median follow-up of 14 years.
Results of the study showed that women with a previous use of estrogen and progestin for fewer than 5 years had a slightly decreased risk for developing lung cancer.
Increasing age at menopause also trended towards a decreased risk of cancer. Increasing number of children trended towards an increased risk.
Researchers also found that women who had their first child between the ages of 20 and 29 had a decreased risk for non-small cell lung cancer specifically, but not lung cancer overall.
No strong associations between lung cancer risk in women and reproductive history and hormone use.
Sign Up for Free e-newsletters
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- American Association for Cancer Research Releases Its 2018 Annual Report
- Pulmonary Toxicity Increased in Pediatric Hodgkin Lymphoma Treated With Brentuximab Vedotin
- Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
- Antioxidant Interaction With Cancer Therapy
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- Myeloablative Conditioning Effective in AML Secondary to MDS/MPN Prior to Allogeneic HCT
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- Endocrine Society Released Guidelines for Managing Endocrine Disorders in Childhood Cancer Survivors
- Skin Cancer Screening: Are They Effective?
- Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT
- CDC: HPV Vaccination Rates on the Rise Among Adolescents
- High-Dose vs Standard-Dose Flu Vaccine in Elderly Receiving Chemotherapy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|